Log in

Forte Biosciences Stock Forecast, Price & News

-1.04 (-2.99 %)
(As of 10/21/2020 12:00 AM ET)
Today's Range
Now: $33.72
50-Day Range
MA: $40.73
52-Week Range
Now: $33.72
Volume59,715 shs
Average Volume87,784 shs
Market Capitalization$377.83 million
P/E RatioN/A
Dividend YieldN/A
Forte Biosciences Inc. operates as a clinical-stage dermatology company in the United States. It is developing a live biotherapeutic FB-401 that has completed Phase 1/2a clinical trial to treat inflammatory skin diseases for pediatric atopic dermatitis patients. The company is based in Torrance, California.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 4.5Community Rank: 3.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.81 out of 5 stars

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Current SymbolNASDAQ:FBRX



Sales & Book Value

Annual Sales$40,000.00
Book Value$6.81 per share


Net Income$-63,520,000.00


Market Cap$377.83 million
Next Earnings Date11/10/2020 (Estimated)
OptionableNot Optionable
-1.04 (-2.99 %)
(As of 10/21/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive FBRX News and Ratings via Email

Sign-up to receive the latest news and ratings for FBRX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Forte Biosciences (NASDAQ:FBRX) Frequently Asked Questions

Do Wall Street analysts recommend investors buy shares of Forte Biosciences?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Forte Biosciences in the last year. There are currently 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Forte Biosciences

When is Forte Biosciences' next earnings date?

Forte Biosciences is scheduled to release its next quarterly earnings announcement on Tuesday, November 10th 2020.
View our earnings forecast for Forte Biosciences

How were Forte Biosciences' earnings last quarter?

Forte Biosciences, Inc. (NASDAQ:FBRX) issued its earnings results on Monday, August, 10th. The company reported ($9.52) earnings per share (EPS) for the quarter.
View Forte Biosciences' earnings history

What price target have analysts set for FBRX?

6 brokerages have issued 12-month price objectives for Forte Biosciences' shares. Their forecasts range from $70.00 to $110.00. On average, they expect Forte Biosciences' stock price to reach $85.00 in the next twelve months. This suggests a possible upside of 152.1% from the stock's current price.
View analysts' price targets for Forte Biosciences

Who are some of Forte Biosciences' key competitors?

What other stocks do shareholders of Forte Biosciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Forte Biosciences investors own include Trevena (TRVN), Ampio Pharmaceuticals (AMPE), Chimerix (CMRX), CorMedix (CRMD), electroCore (ECOR), GalianoGoldInc . (GAU), Great Panther Mining (GPL), Immunic (IMUX), Infinera (INFN) and K12 (LRN).

Who are Forte Biosciences' key executives?

Forte Biosciences' management team includes the following people:
  • Dr. Paul A. Wagner, CEO, Pres & Director (Age 50)
  • Mr. Antony A. Riley, Chief Financial Officer (Age 53)
  • Dr. Daniel J. Burge, Chief Medical Officer (Age 58)
  • Dr. Hank Talbot, Head of Upstream Manufacturing & Quality

What is Forte Biosciences' stock symbol?

Forte Biosciences trades on the NASDAQ under the ticker symbol "FBRX."

Who are Forte Biosciences' major shareholders?

Forte Biosciences' stock is owned by a number of institutional and retail investors. Top institutional shareholders include DAVENPORT & Co LLC (0.24%).

Which major investors are buying Forte Biosciences stock?

FBRX stock was purchased by a variety of institutional investors in the last quarter, including DAVENPORT & Co LLC.

How do I buy shares of Forte Biosciences?

Shares of FBRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Forte Biosciences' stock price today?

One share of FBRX stock can currently be purchased for approximately $33.72.

How big of a company is Forte Biosciences?

Forte Biosciences has a market capitalization of $377.83 million and generates $40,000.00 in revenue each year. The company earns $-63,520,000.00 in net income (profit) each year or ($40.33) on an earnings per share basis. Forte Biosciences employs 5 workers across the globe.

What is Forte Biosciences' official website?

The official website for Forte Biosciences is www.fortebiorx.com.

How can I contact Forte Biosciences?

Forte Biosciences' mailing address is 1124 W CARSON STREET MRL BUILDING 3-320, TORRANCE CA, 90502. The company can be reached via phone at 310-618-6994 or via email at [email protected]

This page was last updated on 10/22/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.